Gemcitabine hydrochloride is a nucleoside analog chemotherapy agent used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer.… Read more





Gemcitabine hydrochloride is a nucleoside analog chemotherapy agent used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer. By acting as a pyrimidine antagonist, it functions by inhibiting DNA synthesis and repair. This category provides high-quality reference standards for gemcitabine hydrochloride, including the active pharmaceutical ingredient, its known process and degradation impurities, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, analytical method development, and validation. Utilizing these analytical standards allows researchers and quality control professionals to accurately identify and quantify related substances during stability testing and routine release analysis, ensuring compliance with regulatory requirements for pharmaceutical manufacturing.